Articles & Reports Archive - The Source on HealthCare Price and Competition

Journal of Health Care Law and Policy

2018 Stuart Rome Lecture: Origins of and Potential Solutions to High Prescription Drug Prices in the U.S.

May 6, 2019

Health Affairs

Zero-Premium Health Insurance Plans Became More Prevalent In Federal Marketplaces In 2018

May 6, 2019

Health Affairs

Why Do Accountable Care Organizations Leave The Medicare Shared Savings Program?

May 6, 2019

Health Affairs

Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries

May 6, 2019

Kaiser Family Foundation

Kaiser Family Foundation / LA Times Survey Of Adults With Employer-Sponsored Health Insurance

May 2, 2019

Congressional Budget Office

Incorporating the Effects of the Proposed Rule on Safe Harbors for Pharmaceutical Rebates in CBO’s Budget Projections—Supplemental Material for Updated Budget Projections: 2019 to 2029

May 2, 2019

NEJM

A New Safe Harbor — Turning Drug Rebates into Discounts in Medicare Part D

May 2, 2019

NEJM

Building on the ACA to Achieve Universal Coverage

May 2, 2019

The Commonwealth Fund

States Step Up to Protect Insurance Markets and Consumers from Short-Term Health Plans

May 2, 2019

GoodRx

GoodRx Quarterly Report: Q1 2019

May 2, 2019

American Academy of Neurology

Out-of-pocket costs are on the rise for commonly prescribed neurologic medications

May 1, 2019

Congressional Budget Office

Key Design Components and Considerations for Establishing a Single-Payer Health Care System

May 1, 2019

Health Affairs Blog

Medicaid Managed Care Programs’ Contracts For Generic Drugs Are Inefficient

May 1, 2019

The Commonwealth Fund

Testimony: Status of U.S. Health Insurance Coverage and the Potential of Recent Congressional Health Reform Bills to Expand Coverage and Lower Consumer Costs

April 30, 2019

Urban Institute

Why Don’t More Medicaid Insurers Sell Plans in ACA Marketplaces?

April 29, 2019

EvaluatePharma

Orphan Drug Report 2019

April 25, 2019